MATK Martek Biosciences Corp. (MM)

Law Offices of Howard G. Smith announces that it is investigating potential claims against the board of directors of Martek Biosciences Corporation (“Martek” or the “Company”) (NASDAQ:MATK) related to the Company’s agreement to be acquired by Royal DSM N.V. The proposed all-cash transaction is valued at approximately $1 billion.

Under the terms of the definitive agreement entered into by the parties, Martek shareholders will receive $31.50 in cash for each share they own of the Company’s common stock. The acquisition is structured as an all-cash tender offer to be followed by a merger in which each remaining share of Martek common stock would be converted into the same cash per share price paid in the tender offer. The tender offer is expected to commence between January 10 and January 25, 2011, and to close in February 2011. The acquisition is expected to close in the first or second quarter of 2011. The investigation concerns possible breaches of fiduciary duty and other violations of law related to approval of the proposed transaction by Martek’s board of directors.

If you are a shareholder of Martek, if you have information or would like to learn more about these claims, or if you wish to discuss these matters or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Howard G. Smith, Esquire, of Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020 by telephone at (215) 638-4847, Toll Free at (888) 638-4847, or by email to howardsmith@howardsmithlaw.com, or visit our website at http://www.howardsmithlaw.com.

Martek (NASDAQ:MATK)
Graphique Historique de l'Action
De Oct 2024 à Nov 2024

Martek (NASDAQ:MATK)
Graphique Historique de l'Action
De Nov 2023 à Nov 2024